We are live on ! Find out more
FVCM

F&V Capital Management Portfolio holdings

AUM $542M
1-Year Est. Return 46.38%
This Fund
S&P 500
This Quarter Est. Return
-1.07%
1 Year Est. Return
+46.38%
3 Year Est. Return
+107.45%
5 Year Est. Return
+141.57%
10 Year Est. Return
+523.33%
AUM
$147M
AUM Growth
+$141K
Cap. Flow
+$2.34M
Cap. Flow %
1.59%
Top 10 Hldgs %
39.05%
Holding
69
New
3
Increased
32
Reduced
24
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 19.77%
2 Healthcare 16.6%
3 Consumer Discretionary 13.69%
4 Consumer Staples 11.16%
5 Financials 10.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATI icon
26
ATI
ATI
$24.3B
$2.77M 1.89%
92,475
+5,915
+7% +$184K
COP icon
27
ConocoPhillips
COP
$144B
$2.72M 1.85%
43,735
+3,475
+9% +$225K
MLI icon
28
Mueller Industries
MLI
$14.5B
$2.54M 1.73%
281,440
+16,340
+6% +$139K
TEX icon
29
Terex
TEX
$7.37B
$2.1M 1.43%
78,910
+2,815
+4% +$71.1K
VMI icon
30
Valmont Industries
VMI
$8.81B
$1.84M 1.25%
14,965
+1,755
+13% +$215K
NEM icon
31
Newmont
NEM
$96.2B
$1.76M 1.2%
81,250
+175
+0.2% +$4.09K
ROP icon
32
Roper Technologies
ROP
$40.4B
$1.75M 1.19%
10,172
-118
-1% -$19.1K
AAPL icon
33
Apple
AAPL
$4.97T
$1.48M 1%
47,440
-80
-0.2% -$2.42K
AIZ icon
34
Assurant
AIZ
$13.9B
$1.03M 0.7%
16,770
-50
-0.3% -$3.17K
CELG
35
DELISTED
Celgene Corp
CELG
$857K 0.58%
7,435
-36,510
-83% -$4.36M
ALV icon
36
Autoliv
ALV
$9.14B
$769K 0.52%
9,075
IBB icon
37
iShares Biotechnology ETF
IBB
$9.45B
$735K 0.5%
6,423
BIDU icon
38
Baidu
BIDU
$35.7B
$718K 0.49%
3,450
-35
-1% -$7.5K
MET icon
39
MetLife
MET
$62.4B
$704K 0.48%
15,635
GOOG icon
40
Alphabet (Google) Class C
GOOG
$4.11T
$702K 0.48%
25,570
ORCL icon
41
Oracle
ORCL
$339B
$684K 0.47%
15,864
-346
-2% -$15K
TGNA
42
DELISTED
TEGNA Inc
TGNA
$650K 0.44%
33,529
-802
-2% -$14.2K
MDVN
43
DELISTED
MEDIVATION, INC.
MDVN
$569K 0.39%
8,820
+600
+7% +$34.4K
DNY
44
DELISTED
DONNELLEY R R & SONS CO
DNY
$502K 0.34%
26,210
-900
-3% -$17.2K
PHM icon
45
Pultegroup
PHM
$25.2B
$485K 0.33%
21,830
BX icon
46
Blackstone
BX
$104B
$462K 0.31%
12,126
-102
-0.8% -$3.69K
HWCC
47
DELISTED
Houston Wire & Cable Company
HWCC
$454K 0.31%
46,673
-132
-0.3% -$1.41K
JNJ icon
48
Johnson & Johnson
JNJ
$640B
$441K 0.3%
4,387
QCOM icon
49
Qualcomm
QCOM
$164B
$440K 0.3%
6,350
-50
-0.8% -$3.52K
SPY icon
50
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$432K 0.29%
2,094
+100
+5% +$20.6K

Similar funds

F&V Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, F&V Capital Management held 69 positions worth $147M, up 0.1% from $147M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

F&V Capital Management's Q1 2015 filing shows 3 new, 32 increased, 24 reduced and 2 closed positions. Its largest new stake was Gilead Sciences: 40,545 shares worth $3.98M. The largest sale was Celgene Corp, an estimated $4.36M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • F&V Capital Management's largest Q1 2015 buy was Gilead Sciences: 40,545 shares worth $3.98M.
  • F&V Capital Management added most to Microsoft in Q1 2015, an estimated $1.95M increase.
  • F&V Capital Management's biggest Q1 2015 reduction was Celgene Corp, cutting an estimated $4.36M.
  • F&V Capital Management fully exited JPMorgan Chase in Q1 2015, selling an estimated $4.22M.
  • F&V Capital Management's ten largest holdings make up 39% of its $147M portfolio in Q1 2015.
  • F&V Capital Management opened 3 new positions and closed 2 in Q1 2015.
  • F&V Capital Management's portfolio value rose 0.1% quarter-over-quarter to $147M.

Based on F&V Capital Management's 13F filing for Q1 2015, filed 10 Apr 2015.